Skip to main content
SleepCited

Effect of valerian on sleep quality in postmenopausal women: a randomized placebo-controlled clinical trial.

Simin Taavoni, Neda Ekbatani, Maryam Kashaniyan, Hamid Haghani
RCT Menopause (New York, N.Y.) 2011 84 citations
PubMed DOI
<\/script>\n
`; }, get iframeSnippet() { const domain = 'sleepcited.com'; const params = 'pmid\u003D21775910'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

Study Type
Randomized Controlled Trial
Population
postmenopausal women
Duration
4.0 weeks
Intervention
Effect of valerian on sleep quality in postmenopausal women: a randomized placebo-controlled clinical trial. 530 mg
Comparator
placebo
Primary Outcome
sleep quality
Effect Direction
Positive
Risk of Bias
Moderate

Abstract

OBJECTIVE: Sleep disturbances reduce the quality of life. About 50% of postmenopausal women experience sleep disturbances such as insomnia. Complementary and alternative medical therapies may be useful for the management of sleep disturbances among postmenopausal women. The aim of the present study was to evaluate the effects of valerian extract taken nightly on the improvement of sleep quality in postmenopausal women experiencing insomnia. METHODS: A randomized, triple-blind, controlled trial design was used for this study. Participants consisted of 100 postmenopausal women aged 50 to 60 years who were experiencing insomnia. A demographic data form and the Pittsburgh Sleep Quality Index were used to collect data. The women were randomly divided into two groups. Each group received either 530 mg of concentrated valerian extract or a placebo twice a day for 4 weeks. Descriptive and inferential statistics were used to analyze the data. RESULTS: A statistically significant change was reported in the quality of sleep of the intervention group in comparison with the placebo group (P < 0.001). Also, 30% of the participants in the intervention group and 4% in the placebo group showed an improvement in the quality of sleep (P < 0.001). CONCLUSIONS: Valerian improves the quality of sleep in women with menopause who are experiencing insomnia. Findings from this study add support to the reported effectiveness of valerian in the clinical management of insomnia.

TL;DR

Valerian improves the quality of sleep in women with menopause who are experiencing insomnia, adding support to the reported effectiveness of valerian in the clinical management of insomnia.

Used In Evidence Reviews

Similar Papers